Intellectual Property News and Reports

Purdue Pharma L.P. (“Purdue”) appeals from a judgment of the Patent Trial and Appeal Board (“Board”) finding claims 1–17 of U.S. Patent No. 9,693,961 (“’961 patent”) unpatentable for lack of written description and anticipation. The Board issued its Final Written... Read more →

Medtronic, Inc. and Medtronic Vascular, Inc. (collectively, “Medtronic”) appeal from two final written decisions of the United States Patent and Trademark Office Patent Trial and Appeal Board (“the Board”) holding that it had not shown the challenged claims of U.S.... Read more →

Allgenesis Biotherapeutics Inc. (Allgenesis) appeals from an inter partes review final written decision in which the Patent Trial and Appeal Board held that Allgenesis failed to prove claims 4 and 5 of U.S. Patent No. 10,149,820 are unpatentable. Because Allgenesis... Read more →